Bluejay Diagnostics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Indranil Dey, with a market cap of $2.0M.
Common questions about Bluejay Diagnostics
Bluejay Diagnostics is scheduled to report earnings for Q1 2026 on May 12, 2026.
Bluejay Diagnostics has approximately 16 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.